Spending on the tests, which analyze genetic material from both people and pathogens, rose 20% year over year in 2024, the analysis found.

Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), announced the completion of its one-millionth DNA/RNA test, underscoring the ...

In a recent blog, I discussed the change in nomenclature for the conditions formerly known as Neurofibromatosis type 2 (NF2) and schwannomatosis. This change was based on the results of an ...

Genetic testing for ATTR can detect transthyretin mutations and offer crucial information about risk, monitoring, and treatment, if needed. Transthyretin amyloidosis (ATTR) is a genetic condition that ...

Genetic testing plays an important role in cystic fibrosis screening and diagnosis. It can help determine if a person has cystic fibrosis or carries gene mutations that cause it. Other tests can also ...

Introduction On January 28, 2026, the U.S. Department of Health and Human Services Office of Inspector General (OIG) released ...

New technology has a history of overwhelming existing systems that try to manage it, and that’s proving to be the case with genetic testing and health care. It’s been only 20 years since the ...

A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...

The CeliacDx offering for Texas marks the company’s first outreach to physicians with additional states planned for later this year. The expansion into physician-ordered testing furthers Targeted ...

DENVER, Colo. (KFSN) -- You've probably heard of companies like ancestry.com or 23-and-me that offer at-home genetic testing. They are just two of more than 11,000 labs in the u-s that offer this. The ...

A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.